Allison Dorval's Net Worth

$8.76 Million

Estimate Recalculated Jul 9, 2024 03:13PM EST

Who is Allison Dorval?

Allison Dorval has an estimated net worth of $8.76 Million. This is based on reported shares across multiple companies, which include INSULET CORP, Voyager Therapeutics, Inc., Verve Therapeutics, Inc., Aerovate Therapeutics, Inc., and PUMA BIOTECHNOLOGY, INC..

SEC CIK

Allison Dorval's CIK is 0001625110

Past Insider Trading and Trends

2021 was Allison Dorval's most active year for acquiring shares with 7 total transactions. Allison Dorval's most active month to acquire stocks was the month of January. 2015 was Allison Dorval's most active year for disposing of shares, totalling 3 transactions. Allison Dorval's most active month to dispose stocks was the month of October. 2023 saw Allison Dorval paying a total of $0.00 for 224,175 shares, this is the most they've acquired in one year. In 2020 Allison Dorval cashed out on 3,128 shares for a total of $41,790.08, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INSULET CORP (PODD) Snapshot price: $198.94

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.13%
-814.00
$31.85
-$25,925.90
37.41K
Apr 1
Form 4
+32.62%
9.4K
$31.37
-$26,695.87
38.23K
Mar 2 - Mar 3
Form 4
-3.65%
-1.09K
$31.73
-$34,617.43
28.83K
Mar 1
Form 4
+33.91%
7.58K
29.92K
Dec 1
Form 3
0
0
No matching records found

Voyager Therapeutics, Inc. (VYGR) Snapshot price: $7.445

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+37.55%
30K
109.89K
Mar 19
Form 4
+74.08%
34K
79.89K
Feb 16
Form 4
-6.49%
-3.19K
$7.55
-$24,054.30
45.89K
Scheduled
Feb 11
Form 4
-5.66%
-2.94K
$8.62
-$25,360.04
49.08K
Scheduled
Jan 12
Form 4
+112.14%
27.5K
52.02K
Feb 10
Form 4
-11.31%
-3.13K
$13.36
-$41,790.08
24.52K
Scheduled
Jan 21
Form 4
+2,260.40%
25K
26.11K
Jan 11
Form 4
0
0
Nov 7
Form 3
0
0
No matching records found

Verve Therapeutics, Inc. (VERV) Snapshot price: $10.97

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Feb 14
Form 4
+48.23%
1.32K
$11.45
-$6,343.30
4.06K
Nov 29
Form 4
0
0
Feb 14
Form 4
+152.72%
1.32K
$22.10
-$12,243.40
2.19K
Nov 29
Form 4
0
0
Feb 11
Form 4
0
0
Nov 29
Form 3
0
0
No matching records found

Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $20.52

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 5
Form 4
0
0
Jun 6
Form 4
0
0
Jun 21
Form 4
0
0
Jul 15
Form 3
0
0
No matching records found

PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $5.035

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+81.82%
27K
60K
Jun 18
Form 4
-25.00%
-11.00K
$3.37
-$37,096.40
33K
Scheduled
Jun 13
Form 4
+62.96%
17K
$3.45
-$34,500.00
44K
Jun 13
Form 4
27K
27K
Jun 14
Form 4
0
0
Jul 15
Form 3
0
0
No matching records found